1 Min Read
Nov 21 (Reuters) - Novo Nordisk
* Says Health Canada has approved a product monograph update for Victoza (liraglutide) Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.